Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth L Savage

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Drug Safety|May 22, 2010
Leflunomide in combination therapy for rheumatoid arthritisRuth L Savage
Diabetes Care|August 27, 2005
Thiazolidinediones and lowered HDL cholesterolRuth L Savage, Anne Kiuru
Drug Safety|January 14, 2018
Case Series Analysis of New Zealand Reports of Rapid Intense Potentiation of Warfarin by RoxithromycinRuth L Savage, Michael V Tatley
The International Journal of Risk & Safety in Medicine|November 9, 2012
Severe muscle symptoms with lipid-lowering agents may be confused with neurogenic claudication associated with spinal canal stenosisRuth L Savage, Kristina Star, Richard Hill
Seminars in Thrombosis and Hemostasis|September 13, 2017
Erratum: International Reports of Unexpected Low Plasma Concentrations of Dabigatran Suggest That More Frequent Measurements Will Add ValueRuth L Savage, Marilina Castellano, Michael V Tatley
Sleep|November 20, 2014
Varenicline and abnormal sleep related eventsRuth L Savage, Alem Zekarias, Pia Caduff-Janosa
Seminars in Thrombosis and Hemostasis|June 14, 2017
International Reports of Unexpected Low Plasma Concentrations of Dabigatran Suggest That More Frequent Measurements Will Add ValueRuth L Savage, Marilina Castellano, Michael V Tatley
The Journal of Rheumatology|January 19, 2008
Alendronate-induced synovitisDavid P Gwynne Jones, Ruth L Savage, John Highton
Drugs - Real World Outcomes|March 31, 2021
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance DatabaseMulugeta Russom, Yodit Fitsum, Abiel Abraham, et al.
Clinical Pharmacokinetics|September 16, 2015
Impact of New Genomic Technologies on Understanding Adverse Drug ReactionsSimran D S Maggo, Ruth L Savage, Martin A Kennedy
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Drug Safety|May 22, 2010
Leflunomide in combination therapy for rheumatoid arthritisRuth L Savage
Diabetes Care|August 27, 2005
Thiazolidinediones and lowered HDL cholesterolRuth L Savage, Anne Kiuru
Drug Safety|January 14, 2018
Case Series Analysis of New Zealand Reports of Rapid Intense Potentiation of Warfarin by RoxithromycinRuth L Savage, Michael V Tatley
The International Journal of Risk & Safety in Medicine|November 9, 2012
Severe muscle symptoms with lipid-lowering agents may be confused with neurogenic claudication associated with spinal canal stenosisRuth L Savage, Kristina Star, Richard Hill
Seminars in Thrombosis and Hemostasis|September 13, 2017
Erratum: International Reports of Unexpected Low Plasma Concentrations of Dabigatran Suggest That More Frequent Measurements Will Add ValueRuth L Savage, Marilina Castellano, Michael V Tatley
Sleep|November 20, 2014
Varenicline and abnormal sleep related eventsRuth L Savage, Alem Zekarias, Pia Caduff-Janosa
Seminars in Thrombosis and Hemostasis|June 14, 2017
International Reports of Unexpected Low Plasma Concentrations of Dabigatran Suggest That More Frequent Measurements Will Add ValueRuth L Savage, Marilina Castellano, Michael V Tatley
The Journal of Rheumatology|January 19, 2008
Alendronate-induced synovitisDavid P Gwynne Jones, Ruth L Savage, John Highton
Drugs - Real World Outcomes|March 31, 2021
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance DatabaseMulugeta Russom, Yodit Fitsum, Abiel Abraham, et al.
Clinical Pharmacokinetics|September 16, 2015
Impact of New Genomic Technologies on Understanding Adverse Drug ReactionsSimran D S Maggo, Ruth L Savage, Martin A Kennedy
Pageof 2